Arthur J Tipton

Birmingham, AL, United States of America

Arthur J Tipton

This inventor holds 43 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 6 EPO patents, primarily in Oral Drug Delivery. Top assignees: Durect Corporation, Atrix Laboratories, Inc., Southern Biosystems, Inc.. Active years: 1991-2018.

USPTO Granted Patents = 43 

% Patents Active = 62.8

 

 

Average Co-Inventor Count = 3.4

ph-index = 30

Forward Citations = 4,101(Granted Patents)


Location History:

  • Fort Collins, CO (US) (1991 - 1999)
  • Homewood, AL (US) (2012 - 2016)
  • Birmingham, AL (US) (1997 - 2018)

Company Filing History:


Years Active: 1991-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oral Drug Delivery
Polymeric Devices
Biodegradable Materials
Controlled Release
Implantable Composites
Liquid Delivery
Zero-Order Release
High Viscosity Systems
Microparticle Processes
Film Dressing
Active Agents
GnRH Compositions
43 patents (USPTO):Explore Patents

Title: The Innovative Journey of Arthur J Tipton

Introduction: Arthur J Tipton, a pioneering inventor hailing from Birmingham, Alabama, has made significant contributions to the world of innovations and patents.

Latest Patents: Arthur J Tipton holds several groundbreaking patents in various fields, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Arthur J Tipton has been at the forefront of cutting-edge inventions, revolutionizing industries and pushing the boundaries of what is possible.

Collaborations: Arthur J Tipton has collaborated with leading experts, companies, and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: Arthur J Tipton's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a visionary inventor in the realm of patents and inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…